An Institutional Animal Care and Use Committee is a federally mandated body that must exist at every research institution using live animals in experiments, testing, or training. The requirement originates in the Animal Welfare Act (7 U.S.C. 2143) and its implementing regulations (9 CFR 2.31), and is reinforced by the Health Research Extension Act of 1985 (42 U.S.C. 289d) for institutions receiving PHS funding.

The IACUC's statutory responsibilities include: reviewing and approving proposed animal-use protocols before research begins; requiring modifications to protocols that do not meet regulatory standards; conducting semiannual inspections of animal facilities; investigating concerns about animal care or noncompliance; and suspending activities that violate approved protocols.

For beagles used in pharmaceutical toxicology, pesticide testing, and biomedical research, the IACUC is the only body that reviews whether a given experiment is justified before the dogs are subjected to it. No external agency pre-approves individual protocols. The USDA inspects facilities and reviews paperwork, but it does not evaluate whether a specific study should proceed.

The fundamental structural flaw of the IACUC system is that it asks institutions to regulate themselves. At least four of the five required members are typically employed by, or professionally dependent on, the institution whose research they are reviewing. The chair, veterinarian, scientist, and non-scientist members are all appointed by the institution's CEO.

Scholarly critique describes a “mission lapse” dynamic in which committees drift toward reliance on trust in the principal investigator rather than conducting robust, independent scientific review. When the reviewer and the reviewed share an employer, funding streams, and professional networks, the incentive structure favors collegial deference over rigorous challenge.

The single unaffiliated member is structurally outnumbered. They may lack scientific training to challenge protocol justifications, they have no institutional power, and their continued appointment depends on the same CEO who appoints the rest of the committee. At private contract research organizations (CROs) — where much beagle testing occurs — the unaffiliated member may be the only person in the room without a financial stake in the protocols being approved.

When a researcher proposes an experiment involving animals, they submit a protocol to the IACUC describing: the species and number of animals requested; the procedures to be performed; the scientific rationale; pain and distress categories; the use of anesthesia, analgesics, or tranquilizers; and a description of the method of euthanasia.

The IACUC may review protocols through one of two mechanisms: full committee review (FCR), where the protocol is discussed and voted on at a convened meeting with a quorum present; or designated member review (DMR), where one or more members are assigned to review and may approve on behalf of the committee, provided no member requests full committee review.

Under 9 CFR 2.31(d), the IACUC must determine that the proposed activities are consistent with the AWA and that procedures will avoid or minimize discomfort, distress, and pain. The committee may approve, require modifications, or withhold approval. A protocol cannot proceed without IACUC sign-off.

However, the regulations include a critical escape valve: painful procedures without anesthesia or analgesia are permitted when “scientifically justified” and documented in writing. The IACUC evaluates that justification, but the bar for what constitutes adequate justification is set by each committee independently, with no external standard.

The AWA regulations require that principal investigators consider alternatives to procedures that may cause more than momentary pain or distress. This requirement is rooted in the 3Rs framework developed by Russell and Burch in 1959:

The AWA (9 CFR 2.31(c)(2)) and PHS Policy both require IACUCs to conduct semiannual inspections of all animal facilities and semiannual reviews of the institution's entire animal care program. After the 21st Century Cures Act (2016), OLAW clarified that PHS-assured institutions may use “flexible approaches” to the semiannual program review, though the semiannual facility inspection requirement remains intact.

These inspections are internal. The IACUC inspects the facilities of the institution that appointed it. Inspection reports are submitted to the institution's Institutional Official (IO), who is also appointed by the institution. Deficiencies must be documented and corrective plans established, but the entire process occurs within the institution's own governance structure.

USDA conducts its own inspections separately, but a CRS report documents litigation alleging that USDA failed to meet annual inspection requirements for certain AAALAC-accredited research facilities since 2019 — suggesting that even the external inspection layer has operated with significant gaps.

The public has almost no visibility into how IACUCs make decisions. Protocol details, committee deliberations, approval/rejection rates, adverse event reports, and compliance discussions are not disclosed to the public. Even the high-level data that does exist — USDA annual reports and inspection records — provides compliance-oriented documentation rather than protocol-level ethical justification or outcomes.

At public universities, some IACUC records may be obtainable through state open-records laws, though institutions frequently resist disclosure citing trade secrets, proprietary information, or security concerns.

At private CROs — where a large volume of beagle testing occurs for pharmaceutical and chemical companies — IACUC minutes, protocols, and internal compliance records are entirely shielded from public access. There is no FOIA equivalent for private institutions. The committee that decides whether a beagle lives or dies in a pesticide study operates in complete secrecy.

The IACUC system's weaknesses are not theoretical. Documented cases demonstrate that committees have approved protocols, or failed to intervene in conditions, that resulted in serious harm:

• Envigo / Cumberland, VA (2022): The DOJ secured the surrender of over 4,000 beagles from a facility where USDA inspectors had repeatedly documented mistreatment. In 2024, the DOJ announced guilty pleas related to conspiracy to violate the AWA and Clean Water Act, characterized as involving the largest agreed-to fine in an AWA case. Reuters reporting described a federal probe scrutinizing why senior USDA animal welfare officials allegedly took limited action despite repeated documentation — raising the question of what role the facility's own IACUC played (or failed to play) as conditions deteriorated.
• Systemic pattern: A USDA Office of Inspector General audit of APHIS oversight documented enforcement weaknesses and recommended improvements in oversight and penalty assessment. The audit found that even when violations were identified, enforcement actions were frequently delayed, reduced, or not pursued — a pattern that implicates the entire oversight chain, including the IACUC layer that is supposed to catch problems before federal inspectors arrive.
• OLAW noncompliance reports: OLAW's model depends on institutions self-reporting noncompliance. By design, the system only surfaces problems that institutions voluntarily disclose. A GAO report on NIH oversight of animal use describes an oversight sequence that depends substantially on internal reporting and referral mechanisms — meaning failures that institutions choose not to report may never be discovered.

Structural reform of the IACUC system has been proposed by scholars, advocates, and some regulatory bodies. The most commonly discussed changes include:

None of these reforms are currently enacted at the federal level. The research industry, through organizations like the National Association for Biomedical Research, actively monitors and opposes legislative proposals that would increase external oversight or transparency requirements.